Acute Infectious Purpura Fulminans with Anticentromere Antibodies

Ikuto Takeuchi¹, Ken-ichi Muramatsu¹, Soichiro Ota¹ and Youichi Yanagawa^1,

¹Department of Acute Critical Care Medicine, Shizuoka Hospital, Juntendo University

Cite this paper

Ikuto Takeuchi, Ken-ichi Muramatsu, Soichiro Ota and Youichi Yanagawa. Acute Infectious Purpura Fulminans with Anticentromere Antibodies. American Journal of Medical Case Reports. 2023; 11(3):52-54. doi: 10.12691/AJMCR-11-3-3

Abstract

Purpura fulminans (PF) is a rare, life-threatening syndrome characterized by disseminated intravascular coagulation (DIC) and endovascular thrombosis resulting in a characteristic pattern of cutaneous purpura. There have been no reports of the combination of PF and anti-centromere antibody (ACA). A 70-year-old woman with a 2-day history of lumbago was transported from a local medical facility to our hospital due to right hydronephrosis due to ureterolithiasis and urosepsis. She had systemic lupus erythematosus (SLE) and schizophrenia. On arrival, she had consciousness disturbance and was in a shock state with cyanotic extremities. She was additionally diagnosed with renal failure, DIC and ACA positivity after examinations. She was treated with vasopressor, antibiotics and ureter stent placement. However, she developed unstable circulation, which necessitated tracheal intubation and continuous hemodiafiltration. Urine and blood cultures showed Escherichia coli. However, the cyanosis of all of her extremities changed to necrosis and she died on day 8 due to multiple organ failure. This is the first case of acute infectious PF with ACA positivity. As ACA is known to be a risk factor for digital necrosis, the present case suggests that in addition to a decrease of protein C or S, ACA may contribute to the development of PF.

Keywords

purpura fulminans, anticentromere antibody, pyelonephritis

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Colling ME, Bendapudi PK. Purpura Fulminans: Mechanism and Management of Dysregulated Hemostasis. Transfus Med Rev. 2018 Apr; 32(2): 69-76.
[2]	Perera TB, Murphy-Lavoie HM. Purpura Fulminans. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. 2022 Jul 18. PMID: 30422460.
[3]	High KA. Antithrombin III, protein C, and protein S. Naturally occurring anticoagulant proteins. Arch Pathol Lab Med. 1988. PMID: 2962557 Review.
[4]	Kuramoto N, Ohmura K, Ikari K, Yano K, Furu M, Yamakawa N, Hashimoto M, Ito H, Fujii T, Murakami K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Taniguchi A, Momohara S, Yamanaka H, Matsuda F, Mimori T, Terao C. Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis. Sci Rep. 2017 Jul 31; 7(1): 6911.
[5]	Sachsenberg-Studer EM, Prins C, Saurat JH, Salomon D. Raynaud's phenomenon, anticentromere antibodies, and digital necrosis without sclerodactyly: an entity independent of scleroderma? J Am Acad Dermatol. 2000 Oct; 43(4): 631-4.
[6]	Bolster L, Taylor-Gjevre RM, Nair B, Gjevre JA. Digital gangrene associated with anticentromere antibodies: a case report. J Med Case Rep. 2010 Jun 22; 4: 189.
[7]	Lowry J, Noel E. A Rare Cause of a Rare Disorder: E. coli-Induced Purpura Fulminans Secondary to Urinary Tract Infection. Case Rep Crit Care. 2022 Apr 6; 2022: 9291424.
[8]	Gamba G, Montani N, Montecucco CM, Caporali R, Ascari E. Purpura fulminans as clinical manifestation of atypical SLE with antiphospholipid antibodies: a case report. Haematologica. 1991 Sep-Oct; 76(5): 426-8.
[9]	Chatterjee S, Pauling JD. Anti-phospholipid syndrome leading to digital ischaemia and rare organ complications in systemic sclerosis and related disorders. Clin Rheumatol. 2021 Jun; 40(6): 2457-2465.
[10]	Demirkaya E, Cakmakli HF, Güçer S, Aktay-Ayaz N, Gürgey A, Ozen S. Purpura fulminans as the presenting manifestation in a patient with juvenile SLE. Turk J Pediatr. 2009 Jul-Aug; 51(4): 378-80.
[11]	Sole K. Mechanisms of thrombosis in antiphospholipid syndrome. Nat Clin Pract Rheumatol. 2006; 2: 176.
[12]	Takahashi M, Okada J, Kondo H. Six cases positive for anti-centromere antibodies with ulcer and gangrene in the extremities. Br J Rheumatol. 1997 Aug; 36(8): 889-93.